HIT Consultant June 10, 2021
Jasmine Pennic

What You Should Know:

Transcarent, a San Francisco, CA-based provider of consumer-directed healthcare to self-insured employers, just announced $58M in Series B funding led by many of the top health and tech investors, bringing its total funding to $98M.

– Led by CEO Glen Tullman, an industry veteran who previously led Livongo and Allscripts, Transcarent is overhauling the self-insured healthcare industry – a market that is long overdue for disruption. Despite numerous efforts and billions of dollars fueling a digital health revolution, employer healthcare costs continue to spiral out of control.

To solve it, Transcarent’s approach is to shift power back to employers who’ve traditionally not had much leverage to negotiate better deals with providers, shouldering much more of...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Digital Health, Insurance, Investments, Self-insured, Technology, Trends
The distressed HealthTech M&A landscape in 2025
Where do the opportunities exist in today's distressed HealthTech M&A landscape in the UK?
Implementation Science: from niche discipline to growing role, influence and future in Healthcare Technology
The Winning Edge: Can Virtual Health Make a Profit?
100+ organizations ask Trump administration to make telehealth controlled substance prescribing permanent

Share This Article